Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
Q4 2023 vs. Q3 2023
How the institutions holding Jasper Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 41 | 42 | +1 |
| Shares | 91.5M | 75.5M | −16.1M (−17.5%) |
| Value | $63.7M | $61.2M | −$2.54M (−4.0%) |
New holders (9)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 3,985,340 | $3.14M | 0.84% |
| Landscape Capital Management, L.L.C. | 789,331 | $622.8K | 0.06% |
| Bank of Montreal | 348,300 | $278.6K | 0.00% |
| Monaco Asset Management SAM | 249,563 | $196.9K | 0.08% |
| Ieq Capital, LLC | 54,500 | $43.0K | 0.00% |
| Jane Street Group, LLC | 11,209 | $8.84K | 0.00% |
| Tower Research Capital LLC (TRC) | 11,144 | $8.79K | 0.00% |
| Royal Bank of Canada | 257 | $0 | 0.00% |
| Simplex Trading, LLC | 26 | $0 | 0.00% |
Sold out (8)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| BVF Inc | 9,900,000 | $6.93M |
| Franklin Resources Inc | 4,500,217 | $3.15M |
| Altium Capital Management LP | 2,868,000 | $2.01M |
| Ikarian Capital, LLC | 1,125,087 | $787.6K |
| Scoggin Management LP | 508,045 | $355.6K |
| Boothbay Fund Management, LLC | 233,159 | $163.2K |
| Forefront Analytics, LLC | 110,792 | $77.6K |
| FMR LLC | 100 | $70 |